Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and Tolerability of a New Fast Disintegrating/Rapid Release Formulation of Sumatriptan Tablets Administered Early in a Migraine Attack
003
Authors/Disclosures
Arnon Karni, MD, PhD (Tel Aviv Sourasky medical center) Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Prof. Karni has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Court. The institution of Prof. Karni has received research support from Medison. The institution of Prof. Karni has received research support from Sanofi. The institution of Prof. Karni has received research support from Novartis. The institution of Prof. Karni has received research support from Roche.
Gianna Carla Riccitelli (San Raffaele) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Mario Di Napoli, MD (ASL Rieti) Dr. Di Napoli has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Susanne Muehlschlegel, MD, MPH, FAAN (Johns Hopkins School of Medicine) Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.